Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
IVA similar filings
- 16 May 24 Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
- 13 May 24 Current report (foreign)
- 13 May 24 Current report (foreign)
- 27 Mar 24 Inventiva reports its 2023 full-year results
- 18 Mar 24 Current report (foreign)
- 7 Mar 24 Inventiva announces that screening in the NATiV3, Phase III, clinical trial evaluating lanifibranor in NASH has resumed
- 15 Feb 24 Inventiva reports preliminary 2023 fiscal year financial Informationˆ and provides an update on its clinical trial NATiV3
Filing view
External links